↓ Skip to main content

MEK inhibitors for the treatment of non-small cell lung cancer

Overview of attention for article published in Journal of Hematology & Oncology, January 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
3 news outlets
twitter
2 X users
patent
1 patent

Citations

dimensions_citation
157 Dimensions

Readers on

mendeley
137 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MEK inhibitors for the treatment of non-small cell lung cancer
Published in
Journal of Hematology & Oncology, January 2021
DOI 10.1186/s13045-020-01025-7
Pubmed ID
Authors

Jing Han, Yang Liu, Sen Yang, Xuan Wu, Hongle Li, Qiming Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 137 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 16%
Student > Master 13 9%
Student > Bachelor 10 7%
Researcher 9 7%
Student > Postgraduate 5 4%
Other 14 10%
Unknown 64 47%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 33 24%
Medicine and Dentistry 16 12%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Agricultural and Biological Sciences 3 2%
Immunology and Microbiology 2 1%
Other 10 7%
Unknown 66 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2024.
All research outputs
#1,584,197
of 25,845,749 outputs
Outputs from Journal of Hematology & Oncology
#98
of 1,305 outputs
Outputs of similar age
#43,283
of 530,147 outputs
Outputs of similar age from Journal of Hematology & Oncology
#5
of 46 outputs
Altmetric has tracked 25,845,749 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,305 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 530,147 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.